Union
Minister of Chemicals & Fertilizers Shri Ananth Kumar launches Cluster
Development Programme for Pharma Sector.
The Union Minister of Chemicals & Fertilizers Shri
Ananth Kumar formally launched the Cluster Development Programme for Pharma
Sector (CDS-PS) here today. Speaking on the occasion, he said that the
programme will provide support to the Pharmaceutical industry in becoming more
capable, productive and competitive. Shri Ananth Kumar said that for the
common man, availability, quality and affordability of drugs and medicines is
of utmost importance and the Cluster Development Programme will be the key step
in ensuring health security of the country. The Minister said that by the
end of this financial year, 06 Pharma Clusters are likely to come up of which
03 will be greenfields. Shri Ananth Kumar said that these Clusters will
ensure adequate testing, training and affluent treatment facilities for
pharmaceuticals industry. The Minister said that the Government will also
come up with the Bulk Drugs Parks and the Medical Devices Parks............................
The Minister of State for Chemicals and Fertilizers Shri Hansraj Gangaram Ahir
said that the Cluster Development Programme is in the interest of the nation as
well as of the society. He said that the private sector is playing a lead
role in the production of Generic medicines and this programme will help in its
holistic expansion..............................................................
The Secretary in the Department of Pharmaceuticals Dr. V.K. Subburaj said that
the Pharmaceutical industry is growing @ 14 to 15% per annum and is likely to
touch the figure of 4 Lakh Crore by 2020. The sector needs due attention
so that the quality can be improved and cost brought down. Dr. Subburaj
said that some Clusters do exist already but not on scientific basis and this
programme is meant to develop Clusters in a scientific manner.....................
The Clusters
Development Programme for Pharma sector would be implemented on a Public
Private Partnership (PPP) format through one time grant-in-aid to be released
for creation of identified infrastructure and common facilities. The
scheme is for setting up of new Clusters as well as up-gradation of existing
Clusters. Rs.125 Crores have been earmarked for the Central Sector Scheme
for the 12th Five Year Plan. The following benefits are
likely to accrue from the programme:-
Ø Increase the competitiveness, easy
access to standard testing facilities and value addition in the domestic pharma
industry especially to SMEs through creation of common world class facilities............................................................................................
Ø Strengthening the existing infrastructure facilities in
order to make Indian Pharma industry a global leader in pharma exports......................................
Ø Reducing the cost of production by up to 20% in the clusters
leading to better availability and affordability medicines in domestic market.
Ø To help industry meet the requirements of standards
environment at a reduced cost through innovative methods of common waste
management..............................
Ø Exploit the benefits arising due to optimization of
resources and economies of scale.............
Posts
No comments:
Post a Comment